# Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

> **NCT00474435** · PHASE2 · UNKNOWN · sponsor: **African Poverty Related Infection Oriented Research Initiative** · enrollment: 30 (estimated)

## Conditions studied

- Tuberculosis
- HIV Infections

## Interventions

- **DRUG:** Emtricitabine/tenofovir/efavirenz

## Key facts

- **NCT ID:** NCT00474435
- **Lead sponsor:** African Poverty Related Infection Oriented Research Initiative
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-12-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00474435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00474435, "Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00474435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*